Hitos de investigación, recaudación de fondos y concienciación de Violehealth.
KCNQ2 is one of the most common causes of neonatal genetic epilepsy. Here is what families and supporters should know.
Invalid Date
Violehealth is preparing its first investigator-initiated grant cycle focused on the KCNQ2 PIP2-binding pathway.
A father turns an impossible diagnosis into a mission to fund gene therapy research for children with KCNQ2 mutations.
